2017

Selecção de dois participantes no curso intensivo IBD - ECCO 2017 Viena
  • Joana Carvalho - CHLN Santa Maria
  • Joana Castela - IPOLFG

2016
  • Bolsas de Investigação 2016/17 

4 bolsas concedidas no valor de 25.000,00€
Projectos premiados

1.     "DEVELOPMENT OF A HISTOPATHOLOGICAL SCORE TO MESURE AND DECIPT INTESTINAL WALL INFLAMMATION AND FIBROSIS IN CD OF THE ILEUM - DIFICIL STUDY" - Helena Tavares de Sousa
2.     “PROSPECTIVE COHORT OF NEWLY DIAGNOSED CROHN'S DISEASE - Crohn's disease Observational Cohort Study" - Joana Torres
3.    
“SWEET: GLYCANS AS NOVEL IMMUNOMODULATORS IN IBD” - Salomé Pinho
4.    
“THE ROLE OF T LYMPHOCYTE DIFFERENTIATION IN IBD - ASSOCIATED COLORECTAL CARCINOMA” - José Carlos Machado

        REGULAMENTO


2015

• Bolsas de investigação 2015/16 - quatro bolsas concedidas no valor de 15.000,00€
Projectos premiados:
  • "Role for the renin-angiotensin system in inflammatory bowel disease: mechanisms and translation" - MANUELA MORATO
  • "Avaliação da expressão de glucagon-like peptide 2 and dipeptidil peptidase 4 em biópsias intestinais de doentes com DII versus controlos e em dois modelos celulares de inflamação intestinal"- PEDRO LOPES
  • "Setting the basis for exploring the co-participation of adherent-invasive Escherichia coli and Mycobacterium avium subsp. paratuberculosis in Crohn's disease" – AMELIA ASSUNÇAO
  • Alterações da coagulação numa população de doentes com doença inflamatória intestinal; Coagulation disorders in a population of patients with inflammatory bowel disease" – JULIANA PINHO

2014
• Bolsas de investigação 2014/15 - seis bolsas concedidas no valor de 15.000,00€
 Projectos premiados:
  • Primary human monocyte culture as in vitro model of IFX pharmacokinetics: Influence of immunogenicity, immunosuppressive agents, albumin and inflammation. -  Joana Afonso
  • The role of gut microbiome, diet, and bile acid metabolism in IBD and in special IBD populations - exploring interactions that may predispose to special phenotypes. - Joana Torres
  • The role of biliary salts malabsorption in inflammatory bowel disease: relationship with butyrate. - Mafalda Couto
  • Genetics variations in FCGR3 receptors: implications in Infliximab therapeutics in inflammatory bowel disease. -  Paula Serrão
  • MGAT5 as a potential new gene determining severity in Inflammatory Bowel Disease. - Salomé Pinho
  • Mesenchymal stem cells in inflamatory bowel disease: therapeutic strategy or cancer promoters? - Sergia Velho


2013
• Bolsas 2013/14 – seis bolsas concedidas no valor de 15.000,00€
 Projectos premiados:
  • Perturbation of the intestinal barrier function in Inflammatory Bowel Diseases: role of the Rac1b /cytokine axis – PETER JORDAN
  • Silent Myocardial Ischemia in Inflammatory Bowel Disease – TIAGO VIEIRA
  • Oxidative Stress and DNA damage in Portuguese IBD patients – CRISTIANA COSTA PEREIRA
  • O papel do glucagon-like peptide 2 e da dipeptidil peptidase 4/CD26 na Doença de Crohn – PEDRO LOPES
  • Lack of response of infliximab in pediatric IBD patient – MARTA TAVARES
  • Screening and monitoring of Epstein-Barr viremia in Patients with Inflammatory Bowel Diseases (IBD) under therapy (5-ASA, azathioprin, infliximab and infliximab plus azathioprin) and in healthy controls – CANDIDA ABREU

2012
• Bolsa de Investigação GEDII 2012/13 (projectos seleccionados)


 
Agenda
De 01 de Janeiro a 31 de Março de 2018
Bolsa de Doutoramento
18 de Janeiro de 2018 Hotel Pestana Cidadela de Cascais
Assembleia Geral
De 18 de Janeiro a 20 de Janeiro de 2018 Lisboa
Reunião Anual GEDII
20 de Janeiro de 2018
Aspectos de Enfermagem em DII
De 14 de Fevereiro a 15 de Fevereiro de 2018 Viena
16th IBD Intensive Advanced Course
©2017 GEDII - Grupo de Estudos da Doença Inflamatória Intestinal | Todos os direitos reservados | Links úteis
Desenvolvido por DogmaSis